Hepatic Hydrothorax: Pathophysiology, Diagnosis, and Management

Journal of Clinical Gastroenterology

Volumn 38, Issue 1, 2004, Pages 52-58

  Garcia Jr , Nelson ^a   Mihas, Anastasios A ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ascites; Cirrhosis; Hepatic hydrothorax; Pleural effusion; Portal hypertension; TIPS

Indexed keywords

DIURETIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT; OCTREOTIDE; SPIRONOLACTONE; TAMOXIFEN;

ALGORITHM; ASCITES; DIAGNOSTIC TEST; DISEASE SEVERITY; HUMAN; HYDROTHORAX; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; PATHOGENESIS; PLEURA EFFUSION; PLEURODESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; THORAX DRAINAGE;

CHRONIC DISEASE; CHYLOTHORAX; COMBINED MODALITY THERAPY; EMPYEMA, PLEURAL; HUMANS; HYDROTHORAX; LIVER DISEASES; PERITONEOVENOUS SHUNT; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; THORACOSTOMY;

EID: 0346118829     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200401000-00012     Document Type: Review

References (81)

1. Lieberman FL, Hidemura R, Peters RL, et al. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med. 1966;64:341-351.
2. Islam N, Ali S, Kabir H. Hepatic hydrothorax. Br J Dis Chest. 1965;59:222-227.
3. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis. 1997;17:227-232.
4. Xiol X, Guardiola J. Hepatic hydrothorax. Curr Opin Pulm Med. 1998;4:239-242.
5. Lazaridis KN, Frank JW, Krowka MJ, et al. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999;107:262-267.
6. Kirsch CM, Chui DW, Yenokida GG, et al. Case report: hepatic hydrothorax without ascites. Am J Med Sci. 1991;302:103-106.
7. Andrade RJ, Martin-Palanca A, Fraile JM, et al. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol. 1996;22:305-307.
8. Kakizaki S, Katakai K, Yoshinaga T, et al. Hepatic hydrothorax in the absence of ascites. Liver. 1998;18:216-220.
9. Truninger K, Frey LD. Hepatic hydrothorax without ascites. Schweiz Med Wochenschr. 2000;130:1706.
10. Layden TJ, Kulik L. Hepatic manifestations of pulmonary diseases. Clin Liver Dis. 2002;6:969-979.
11. Jones EG. Hepatic hydrothorax: a retrospective case study. J Am Acad Nurse Pract. 2001;13:209-214.
12. Emerson PA, Davies JH. Hydrothorax complicating ascites. Lancet. 1955;1:487-488.
13. Meigs JV, Armstrong SH, Hamilton HH. A further contribution to the syndrome of fibroma of the ovary with fluid in the abdomen and chest: Meigs syndrome. Am J Obstet Gynecol. 1943;46:19-37.
14. Higgins G, Kelsall AR, O'Brien JRP, et al. Ascites in chronic disease of the liver. Q J Med. 1947;16:263-274.
15. Dumont AE, Mulholland JH. Flow rate and composition of thoracic duct lymph in patients with cirrhosis. N Engl J Med. 1960;263:471-474.
16. Montanari M, Orsi P, Pugliano G. Hepatic hydrothorax without diaphragmatic defect. An original surgical treatment. J Cardiovasc Surg (Torino). 1996;37:425-427.
17. Mouroux J, Perrin C, Venissac N, et al. Management of pleural effusion of cirrhotic origin. Chest. 1996;109:1093-1096.
18. Mittal BR, Maini A, Das BK. Peritoneopleural communication associated with cirrhotic ascites: scintigraphic demonstration. Abdom Imaging. 1996;21:69-70.
19. Serena A, Aliaga L, Richter JA, et al. Scintigraphic demonstration of a diaphragmatic defect as the cause of massive hydrothorax in cirrhosis. Eur J Nucl Med. 1985;11:46-48.
20. Benet A, Vidal F, Toda R, et al. Diagnosis of hepatic hydrothorax in the absence of ascites by intraperitoneal injection of 99m-Tc-Fluor colloid. Postgrad Med J. 1992;68:153.
21. Rubinstein D, McInnes IE, Dudley FJ. Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. Gastroenterology. 1985;88:188-191.
22. Chen A, Ho YS, Tu YC, et al. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol. 1988;10:663-666.
23. Chen A. Massive hydrothorax complicating liver cirrhosis as a result of a diaphragmatic defect. Respiration. 1988;54:206-207.
24. Lau KK, Arkles B, McKenzie A. A case of hepatic hydrothorax due to a large diaphragmatic defect. Australas Radiol. 1992;36:160-162.
25. Milanez deCampos Jr., Filho LO, de Campos WE, et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest. 2000;118:13-17.
26. Albano G, Pugliese A, Stabile M, et al. Hydrops foetalis caused by hepatic haemangioma. Acta Paediatr. 1998;87:1307-1309.
27. Miksad R, de Ledinghem V, McDougall C, et al. Hepatic hydrothorax associated with vitamin A toxicity. J Clin Gastroenterol. 2002;34:275-279.
28. Nolop KB. Massive hydrothorax complicating occult cirrhosis. South Med J. 1985;78:214-215.
29. Mentes BB, Kayhan B, Gorgul A, et al. Hepatic hydrothorax in the absence of ascites: report of two cases and review of the mechanism. DigDis Sci. 1997;42:781-788.
30. Giacobbe A, Facciorusso D, Tonti P, et al. Hydrothorax complicating cirrhosis in the absence of ascites. J Clin Gastroenterol. 1993;17:271-272.
31. Shah A, Variyam E. Pericardial effusion and left ventricular dysfunction associated with ascites secondary to hepatic cirrhosis. Arch Intern Med. 1988;148:585-588.
32. Kaplan LM, Epstein SK, Schwartz SL, et al. Clinical, echocardiographic and hemodynamic evidence of cardiac tamponade caused by large pleural effusions. Am J Respir Crit Care Med. 1995;151:904-908.
33. Ackerman Z, Reynolds TB. Evaluation of pleural fluid in patients with cirrhosis. J Clin Gastroenterol. 1997;25:619-622.
34. Xiol X, Castellvi JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology. 1996;23:719-723.
35. Xiol X, Castellote J, Baliellas C, et al. Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases. Hepatology. 1990;11:365-370.
36. Light RW. Pleural Disease. 3rd ed. Baltimore: Williams & Wilkins; 1995:36-74.
37. Bhattacharya A, Mittal BR, Biswas T, et al. Radioisotope scintigraphy in the diagnosis of hepatic hydrothorax. J Gastroenterol Hepatol. 2001;16:317-321.
38. Holt KA, Oliviera E, Rohatgi PK. Hepatic hydrothorax demonstration by Tc-99m sulfur colloid ascites scan. Clin Nucl Med. 1999;24:609.
39. Giacobbe A, Facciorusso D, Barbano F, et al. Hepatic hydrothorax. Diagnosis and management. Clin Nucl Med. 1996;21:56-60.
40. Rajnish A, Sudhakar P. Diagnosis of hepatic hydrothorax by Tc-99m sulfur colloid peritoneal scintigraphy. Clin Nucl Med. 2001;26:888.
41. Schuster DM, Mukundan S Jr, Small W, et al. The use of the diagnostic radionuclide ascites scan to facilitate treatment decisions for hepatic hydrothorax. Clin Nucl Med. 1998;23:16-18.
42. Zenda T, Miyamoto S, Murata S, et al. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging. Am J Gastroenterol. 1998;93:2288-2289.
43. Runyon BA, Greenblatt M, Ming RHC. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol. 1986;81:566-567.
44. Raju EP, Rao PN, Venkateswarlu J, et al. Ultrasound documentation of diaphragmatic rent in hepatic hydrothorax. Indian J Gastroenterol. 1989;8:111-112.
45. Sawabe J, Ishida H, Niizawa M, et al. Sonographic demonstration of diaphragmatic fistula in a patient with hepatic hydrothorax. Akita J Med. 1992;19:615-619.
46. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001;120:726-748.
47. Gentilini P, Casini-Raggi V, Di Fiore G, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol. 1999;30:639-645.
48. Garcia N Jr, Sanyal AJ. Minimizing ascites. Complication of cirrhosis signals clinical deterioration. Postgrad Med. 2001;109:91-93.
49. Li CP, Lee FY, Hwang SJ, et al. Treatment of mastalgia with tamoxifen in male patients with liver cirrhosis: a randomized crossover study. Am J Gastroenterol. 2000;95:1051-1055.
50. Dumortier J, Lepretre J, Scalone O, et al. Successful treatment of hepatic hydrothorax with octreotide. Eur J Gastroenterol Hepatol. 2000;12:817-820.
51. Pfammatter R, Quattropani C, Reichen J, et al. Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide. Eur J Gastroenterol Hepatol. 2001;13:977-980.
52. Strauss RM, Martin LG, Kaufman SL, et al. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol. 1994;89:1520-1522.
53. Chalasani N, Gitlin N. TIPS for patients with refractory hepatic hydrothorax: what is the take-home message? Am J Gastroenterol. 1997;92:2129-2130.
54. Gordon FD, Anastopoulos HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology. 1997;25:1366-1369.
55. Degawa M, Hamasaki K, Yano K, et al. Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt. J Gastroenterol. 1999;34:128-131.
56. Conklin LD, Estrera AL, Weiner MA, et al. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg. 2000;69:609-611.
57. Siegerstetter V, Deibert P, Ochs A, et al. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13:529-534.
58. Nunez O, Garcia A, Rincon D, et al. Percutaneous intrahepatic portosystemic shubting as a treatment for refractory hepatic hydrothorax. Gastroenterol Hepatol. 2002;25:143-147.
59. Spencer EB, Cohen DT, Darey MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol. 2002;13:385-390.
60. Chalasani N, Clark WS, Martin LG, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology. 2000;118:138-144.
61. Sanyal AJ. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep. 2000;2:61-71.
62. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-871.
63. Sanyal AJ, Genning C, Reddy KR, et al. and the NASTRA Group. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124:634-641.
64. Falchuk KR, Jacoby I, Colucci WS, et al. Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis. A new approach to treatment. Gastroenterology. 1977;72:319-321.
65. Temes RT, Davis MS, Follis FM, et al. Videothoracoscopic treatment of hepatic hydrothorax. Ann Thorac Surg. 1997;64:1468-1469.
66. Yaguchi T, Harada A, Sakakibara T, et al. A successful surgical repair of the hepatic hydrothorax using pneumoperitoneum: report of a case. Surg Today. 1999;29:795-798.
67. Ferrante D, Arguedas MR, Cerfolio RJ, et al. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol. 2002;97:3172-3175.
68. LeVeen HH, Piccone VA, Hutto RB. Management of ascites with hydrothorax. Am J Surg. 1984;148:210-213.
69. Ghandour E, Carter J, Feola M, et al. Management of hepatic hydrothorax with a peritoneovenous (Denver) shunt. South Med J. 1990;83:718-719.
70. Stanley MM, Ochi S, Lee KK, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis and Ascites. N Engl J Med. 1989;321:1675-1677.
71. Arroyo V, Gines P, Planas R. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large volume paracentesis. Gastroenterol Clin North Am. 1993;21:237-256.
72. Gines P, Arroyo V, Vargas V, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 1991;325:829-835.
73. Deen KI, de Silva AP, Jayakody M, et al. Saphenoperitoneal anastomosis for resistant ascites in patients with cirrhosis. Am J Surg. 2001;181:145-148.
74. Spreafico C, Patelli G, Lanocita R, et al. Percutaneous implant of Denver peritoneovenous shunt: a new opportunity for the interventional radiologist. Radiol Med. 2001;102:154-158.
75. Wang JT, Fang CT, Hsueh PR, et al. Spontaneous bacterial empyema caused by Aeromonas veronii biotype sobria. Diagn Microbiol Infect Dis. 2000;37:271-273.
76. Runyon BA, Umland ET, Merlin T. Inoculation of blood culture bottles with ascitic fluid. Improved detection of spontaneous bacterial peritonitis. Arch Intern Med. 1987;147:73-75.
77. Sese E, Xiol X, Castellote J, et al. Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema. J Clin Gastroenterol. 2003;36:75-77.
78. Abba AA, Laajam MA, Zargar SA. Spontaneous neutrocytic hepatic hydrothorax without ascites. Respir Med. 1996;90:631-634.
79. Goulis J, Armonis A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998;27:1207-1212.
80. Romero S, Martin C, Hernandez L, et al. Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics. Chest. 1998;114:154-159.
81. Milsom JW, Kron IL, Rheuban KS, et al. Chylothorax: an assessment of current surgical management. J Thorac Cardiovasc Surg. 1985;89:221-227.